BNP Paribas Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

BNP Paribas Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.6K	Sell	1,098 -250	-19%	-$4.37K	﹤0.01%	2101
2026 Q1	$25.8K	Buy	1,348 +369	+38%	+$8.02K	﹤0.01%	1944
2025 Q4	$22K	Buy	979 +271	+38%	+$4.89K	﹤0.01%	1932
2025 Q3	$9K	Buy	708 +50	+8%	+$677	﹤0.01%	1679
2025 Q2	$12K	Buy	+658	New	+$13K	﹤0.01%	1719
2023 Q3	–	Sell	-427,025	Closed	-$10.5M	–	861
2023 Q2	$10.5M	Sell	427,025 -27,525	-6%	-$886K	0.03%	392
2023 Q1	$18.5M	Buy	454,550 +87,002	+24%	+$3.6M	0.06%	305
2022 Q4	$16.5M	Buy	+367,548	New	+$16.6M	0.06%	340

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

BNP Paribas Asset Management's TNDM Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Tandem Diabetes Care (TNDM) stake by 19% in Q2 2026, selling an estimated $4.37K and leaving 1,098 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2101.

BNP Paribas Asset Management first reported a position in TNDM in Q4 2022 and has held it in 8 quarters since. The position peaked at $18.5M in Q1 2023. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

BNP Paribas Asset Management held 1,098 shares of Tandem Diabetes Care worth $16.6K as of Q2 2026.
BNP Paribas Asset Management sold 250 Tandem Diabetes Care shares in Q2 2026, an estimated $4.37K.
Tandem Diabetes Care made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2101 holding.
BNP Paribas Asset Management first reported a position in Tandem Diabetes Care in Q4 2022 and has held it in 8 quarters since.
BNP Paribas Asset Management's Tandem Diabetes Care position peaked at $18.5M in Q1 2023.
274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.